As of January 22, 2025, Reneo Pharmaceuticals (RPHM) has a market cap of $60.840 million USD. According to our data, Reneo Pharmaceuticals is ranked No.8039 in global market value.
Year | Market Cap | %Change |
---|---|---|
Oct 04, 2024 | $60.84 M |
13.75%
|
Dec 29, 2023 | $53.49 M |
-31.33%
|
Dec 30, 2022 | $77.89 M |
-72.75%
|
Dec 31, 2021 | $0.29 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Solid Biosciences
SLDB
|
$0.12 B |
-0.000 M
|
USA
|
Boundless Bio
BOLD
|
$57.31 M |
0.000 M
|
USA
|
Cytokinetics
CYTK
|
$5.53 B |
-0.000 M
|
USA
|
Market Cap | = | RPHM Stock Price | * | RPHM Shares Outstanding |
= | $18.20 | * | 3.34 M | |
= | $60.84 M |